[1]CurrentPatentAssignee:TIOGAPHARMACEUTICALSINC-US5532266,1996,A
[1]CurrentPatentAssignee:TIOGAPHARMACEUTICALSINC-US5532266,1996,A
[1]Tetrahedron,2013,vol.69,p.9890-9897
Title: Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.
Journal: Clinical and experimental gastroenterology 20120101
Title: Drug management of visceral pain: concepts from basic research.
Journal: Pain research and treatment 20120101
Title: The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain.
Journal: European journal of pharmacology 20111205
Title: Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.
Journal: Gut and liver 20110901
Title: SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects.
Journal: European journal of pharmacology 20101125
Title: Asimadoline in the treatment of irritable bowel syndrome.
Journal: Expert opinion on investigational drugs 20101001
Title: Involvement of kappa-opioid receptors in visceral nociception in mice.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20081001
Title: Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080901
Title: Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Journal: Alimentary pharmacology & therapeutics 20080701
Title: Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.
Journal: Alimentary pharmacology & therapeutics 20080601
Title: Opioid-induced bowel dysfunction.
Journal: Current treatment options in gastroenterology 20080201
Title: Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
Journal: European journal of pharmacology 20071114
Title: Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071101
Title: Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists.
Journal: The Journal of pharmacology and experimental therapeutics 20061101
Title: Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.
Journal: Diabetologia 20061101
Title: Peripheral opioids for functional GI disease: a reappraisal.
Journal: Digestive diseases (Basel, Switzerland) 20060101
Title: Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.
Journal: Therapeutics and clinical risk management 20051201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20041101
Title: The kappa-opioid receptor agonist asimadoline inhibits epithelial transport in mouse trachea and colon.
Journal: European journal of pharmacology 20041025
Title: Functional dyspepsia: drugs for new (and old) therapeutic targets.
Journal: Best practice & research. Clinical gastroenterology 20040801
Title: Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
Journal: Alimentary pharmacology & therapeutics 20040715
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20040301
Title: Arylacetamide kappa-opioid receptor agonists produce a tonic- and use-dependent block of tetrodotoxin-sensitive and -resistant sodium currents in colon sensory neurons.
Journal: The Journal of pharmacology and experimental therapeutics 20031001
Title: Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health.
Journal: Alimentary pharmacology & therapeutics 20030901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030601
Title: Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20030401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20030101
Title: CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502.
Journal: The Journal of antibiotics 20021001
Title: The kappa-opioid agonist, asimadoline, alters cytokine gene expression in adjuvant arthritis.
Journal: Rheumatology (Oxford, England) 20010901
Title: Camilleri M, et al. Asimadoline, a κ-Opioid Agonist, and Visceral Sensation. Neurogastroenterol Motil. 2008 Sep; 20(9): 971–979.
Title: Binder W, et al. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171. Eur J Neurosci. 1999 Jun;11(6):2065-72.
Title: C G Jolivalt, et al. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia. 2006 Nov;49(11):2775-85.
